Feature | March 18, 2014

Document Addresses PCI Quality, Safety

March 18, 2014 — The increasing number of percutaneous coronary interventions (PCIs) being performed at low-volume centers without on-site cardiac surgery backup has driven the need for new safety and quality protocols. This is according to an expert consensus document written by a committee representing the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). The document outlines steps hospitals can take to provide the safest possible environment for PCI when the facility does not provide cardiac surgery as a backup should complications occur.

"This issue was last reviewed in 2007, and since that time interventional cardiology has seen important changes," said Gregory J. Dehmer, M.D., FACC, FSCAI, director of the Division of Cardiology at Baylor Scott & White Health, Central Texas (Temple, Texas) and the document's lead author. "The new recommendations aim to increase safety while maintaining access to quality care for underserved patients."

Although PCI use increased significantly since the procedure was introduced more than 30 years ago, for a variety of reasons use peaked in 2006 and has since dropped by nearly a third. Advances in drug-eluting stents, greater use of medication to treat some types of blockages, increased emphasis on heart disease prevention, and new technologies to help physicians better evaluate blockages have all contributed to a drop in PCI use.

This drop has led to an increase in the number of facilities that are considered "low volume," or performing fewer than 200 PCIs per year, according to the consensus document. Overall, one-third of facilities performing PCI had no on-site cardiac surgery, and among those hospitals, about two-thirds were considered low volume.

The consensus document cites studies and meta-analyses since 2006 that find no indication of increased mortality or a greater need for emergency bypass surgery for either heart attack or elective PCI patients at sites without on-site cardiac surgery. In general, it said, safety questions about sites without surgical backup have diminished "in the presence of a proven, well-defined and protocol-driven approach."

However, the paper echoed an earlier joint recommendation that low-volume PCI programs "must have stringent systems and process protocols in place" with close monitoring of outcomes and strategies that encourage collaboration with higher-volume facilities.

"As the technique and equipment for PCI has improved, the evidence from randomized studies suggests that procedures can be performed safely without on-site surgery," said Dehmer. "But at the same time, the number of low-volume centers is increasing, making it essential that those facilities without backup cardiac surgery have strict protocols in place to ensure the highest level of patient safety."

The consensus document compiles the recommendations made by various organizations in several different documents into one resource for use by facilities without on-site surgery. These include a greater emphasis on quality review programs, the recommended number of procedures physicians should perform per year to maintain their skills, mentoring for newly trained cardiologists and criteria to evaluate PCI programs. It also recommends a shift in focus to system-wide planning for rational distribution of PCI services.

"The expansion of small PCI programs without on-site surgery has not substantially improved access to PCI," said Dehmer. "Although the number of facilities capable of performing PCI has increased 44 percent, the number of people who live within a one-hour drive of a PCI facility has increased only slightly. Today about 80 percent of the population is within one-hour of a PCI hospital." Recent surveys found expansion of PCI reduced drive times for just 9 percent of the population.

The document also supports the ongoing study and surveillance of all PCI programs through participation in national databases, encourages public reporting of results and acknowledges further declines in PCI volumes might necessitate the closure of some PCI programs in the future.

The consensus document, titled, "SCAI/ACCF/AHA Expert Consensus Document Update on Percutaneous Coronary Intervention without On-Site Surgical Backup," updates a 2007 consensus document. It was published online in Catheterization & Cardiovascular Interventions, Journal of the American College of Cardiology (JACC) and Circulation: Journal of the American Heart Association.

For more information: onlinelibrary.wiley.com

Related Content

bioresorbable stents, bioabsorbable stents, visualizing the Absorb BVS, dissolving stent, disappearing stent on IVUS and OCT

A comparison of how the Abbott Absorb BVS appears with intravascular ultrasound (IVUS) on the left, and optical coherence tomography (OCT) of the right. The stent is difficult to visualize and sizing is critical, so both modalities can help in bioresorbable stent measurements and to confirm stent apposition. Left image from the Volcano IVUS system and the right image from St. Jude Medical's OCT system


Feature | Stents Bioresorbable| October 20, 2016 | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular S
Avinger, Pantheris atherectomy catheter, OCT, Lumivascular technology, expanded FDA indication, diagnostic imaging device
News | Atherectomy Devices| October 20, 2016
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug...
recall, alligator retrieval device, X-Celerator hydrophilic guidewire, UltraFlow flow directed micro catheters, Marathon flow directed micro catheters
News | Cath Lab| October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
Inventory management, Cardinal, RFID inventory tracking, cath lab inventory
Sponsored Content | Whitepapers | Inventory Management| October 18, 2016
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of
angioseal, angio-seal, terumo, St. Jude, vascular closure devices
News | Vascular Closure Devices| October 18, 2016
October 18, 2016 — Abbott and St. Jude Medical Inc.
3-D bioprinting, 3-D printing, printed organs, 3D bioprinting

3-D printed vessel made from living cells implanted in an animal to test feasibility of using such structures clinically. Blood vessels are a stepping stone to the creation of more complex 3-D printed organs made from biomaterials. Image from the South Carolina Project for Organ Biofabrication.


Feature | 3-D Printing| October 13, 2016 | Dave Fornell
The U.S. Food and Drug Administration (FDA) changed its rules concerning custom medical devices Oct.
Shockwave lithoplasty system, VIVA 16, Vascular Interventioanl Advances, VIA Physicians, late-breaking endovascular clinical trial results
News | Cath Lab| October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...
Terumo Finecross, guidewires, guide wires, guidewires 101, basics of guidewire technology

An illustration of Terumo's Finecross guidewire crossing a tight lesion. 

Feature | Guidewires| October 12, 2016 | Dave Fornell
While guidewires are a key tool used by
Medtronic, FDA clearance, TrailBlazer peripheral angled support catheter, PAD, peripheral artery disease
Technology | Peripheral Arterial Disease (PAD)| October 12, 2016
Medtronic plc announced recently that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer angled...
Cardioband, first tricuspid valve repair, University Hospital Zurich, Francesco Maisano
News | Heart Valve Technology| October 10, 2016
Francesco Maisano, clinic director at the University Hospital Zurich, recently led a team of cardiac surgeons and...
Overlay Init